Highly mobile, invasive ovarian cancer cells called ‘leader cells’ have been identified as leading the attack on healthy tissue.
Dr Maree Bilandzic explains this pivitol discovery, published in Cancers, and the significance of leader cells in finding more effective therapies for ovarian cancer.
Collaborators
Monash University, Bruker Biosciences Pty Ltd, Monash Health, RMIT University
Funders
Contributing to Australian Scholarship in Science (CASS) foundation, Ovarian Cancer Research Foundation, Victorian Government’s Operational Infrastructure Support Program
/Public Release. View in full here.
